STAMFORD, Conn. and DANVILLE, Pa. – The first patient has been enrolled in a joint Purdue Pharma/Geisinger study on the effects of wearables on treating chronic pain. The study is designed to demonstrate how the use of wearable health technology by chronic pain patients treated at a specialty clinic may improve both patient and healthcare system outcomes. The study will use an Apple Watch to take measures to guide the patient toward non-pharmaceutical treatment alternatives. “The goal of this technology is to improve patient function and quality of life while reducing the need for analgesic medications,” said Dr. Tracy Mayne, head of strategic research at Purdue Pharma, in a statement. The Apple Watch will include a pain app developed for this study and a healthcare provider dashboard, and will integrate with Geisinger’s electronic medical record. “We are incorporating advanced technology into the traditional healthcare setting to redirect and empower the patient to take more control of their own well-being,” said Dr. John Han, director of the department of pain medicine at Geisinger, in a statement.
You are here: / / Purdue Pharma, Geisinger to study mHealth effect on chronic pain